Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906824 · ClinicalTrials.gov registry record
Post-Market Registry in Europe and US for the Use of VascuCelTM
A clinical trial of Great Vessel Reconstruction and Peripheral Vessel Reconstruction, sponsored by LeMaitre Vascular.
- Active
- Registry status
- 100
- Enrollment target
- 5
- Study locations
NCT04906824 is a study of Great Vessel Reconstruction and Peripheral Vessel Reconstruction that is active but no longer recruiting, run by LeMaitre Vascular. The registered enrollment target is 100 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT04906824, a study of Great Vessel Reconstruction and Peripheral Vessel Reconstruction, is active but no longer recruiting, sponsored by LeMaitre Vascular.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and performance data up to 2 years following implantation.
Conditions Studied
Interventions
- DEVICE great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing
Study Locations (5)
Idaho
- Kootenai Health - Coeur d'Alene
Nevada
- Eddy Luh - Las Vegas
New York
- Westchester Medical Center - Valhalla
North Carolina
- University North Carolina - Chapel Hill
Other
- ASST Sette Laghi Varese - Varese
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04906824
The ClinicalTrials.gov registry entry for NCT04906824 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LeMaitre Vascular, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Great Vessel Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing is the first listed.
NCT04906824 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Idaho, Nevada, New York.
Frequently Asked Questions
What is clinical trial NCT04906824 about?
NCT04906824 is a clinical study titled "Post-Market Registry in Europe and US for the Use of VascuCelTM". This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and perfor...
What is the current status of trial NCT04906824?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2023-06-09. Estimated completion is 2026-09.
What conditions does trial NCT04906824 study?
This clinical trial studies the following conditions: Great Vessel Reconstruction, Peripheral Vessel Reconstruction, Suture Line Buttressing.
What interventions are being tested in trial NCT04906824?
The interventions under investigation include: great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing (DEVICE).
Who is sponsoring clinical trial NCT04906824?
This trial is sponsored by LeMaitre Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04906824 being conducted?
This trial has 5 study locations across Idaho, Nevada, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.